FIB-4 is recommended as an initial screening test for advanced fibrosis and is calculated using readily available patient information that includes age, AST, ALT, and platelet count
The peptide dissolves readily in bacteriostatic water without needing the osmolality adjustment that saline provides
Proof of Brand-Name GLP-1 Drug Use To qualify, you must provide evidence that you used a brand-name GLP-1 receptor agonist , such as: Ozempic Trulicity Wegovy Mounjaro Rybelsus Zepbound Acceptable proof may include prescription records, medical charts showing the medication was prescribed, or pharmacy packaging labeled with your name
And remember, alcohol can worsen dehydration and may hit harder when youre eating less, so keep it in moderation and avoid drinking on an empty stomach (8)
Read the guide Medicaid & dual-eligible How Washington Apple Health and Medicare intersect for dual-eligible beneficiaries including Extra Help, D-SNPs, and 2026 asset limit updates
BPC-157 has not been proven safe or effective for any condition and is not eligible for inclusion on the 503B Bulks List for compounding. FDA Review Memorandum, 2023 In other words, BPC157 does not meet FDA standards for legal use in clinical practice
